"Is Colin Farrell married?" has been a burning question among fans of the Irish actor. He is single & unmarried despite being ...
5d
Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted ...
The biggest marathon in the U.S. also attracted some of the biggest stars in entertainment. This year, dozens of notable participants across television, music, and sports ran the New York City ...
The latest tranche of emails and other documents released from Jeffrey Epstein’s estate has raised more questions about the reach of the disgraced financier’s post-conviction influence and access to ...
A lot has changed in fashion over the past quarter century. Brands came and went. Pants were baggy then they were skinny, then baggy again. Brands once considered titans of the subculture known as ...
MIDDLETON, Mass., Nov. 6, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Ultragenyx Pharmaceutical ( (RARE)) just ...
On Monday, the hottest spot in Los Angeles wasn't the Chateau Marmont—it was Game 3 of the World Series. Indeed, celebrities and professional athletes descended upon Dodger Stadium in droves to watch ...
Celebrities are mourning the loss of Diane Keaton, who died at age 79. People broke the news of her death on Saturday, October 11, confirming that The Godfather star died in California. Further ...
According to a recent disclosure with the SEC, Assenagon Asset Management S.A. lifted its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) by a whopping 439.0% during the second quarter.
On Tuesday, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to Ionis Pharmaceuticals Inc.’s (NASDAQ:IONS) ION582 for Angelman syndrome (AS), a rare neurological ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ION582 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback